Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.
Belhadj K, Delfau-Larue MH, Elgnaoui T, Beaujean F, Beaumont JL, Pautas C, Gaillard I, Kirova Y, Allain A, Gaulard P, Farcet JP, Reyes F, Haioun C. Belhadj K, et al. Among authors: farcet jp. Ann Oncol. 2004 Mar;15(3):504-10. doi: 10.1093/annonc/mdh090. Ann Oncol. 2004. PMID: 14998857 Free article.
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, Feugier P, Rabian C, Casasnovas O, Labalette M, Kuhlein E, Farcet JP, Emile JF, Gisselbrecht C, Delfau-Larue MH; Groupe d'étude des lymphomes de l'adulte. Plonquet A, et al. Among authors: farcet jp. Ann Oncol. 2007 Jul;18(7):1209-15. doi: 10.1093/annonc/mdm110. Epub 2007 May 12. Ann Oncol. 2007. PMID: 17496307 Free article. Clinical Trial.
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages.
Carbonnelle-Puscian A, Copie-Bergman C, Baia M, Martin-Garcia N, Allory Y, Haioun C, Crémades A, Abd-Alsamad I, Farcet JP, Gaulard P, Castellano F, Molinier-Frenkel V. Carbonnelle-Puscian A, et al. Among authors: farcet jp. Leukemia. 2009 May;23(5):952-60. doi: 10.1038/leu.2008.380. Epub 2009 Jan 29. Leukemia. 2009. PMID: 19436310 Free PMC article.
Peripheral blood lymphocyte phenotypes in patients with spondyloarthropathy.
Plonquet A, Gleizes A, Briot K, Maison P, Chevalier X, Farcet JP, Claudepierre P. Plonquet A, et al. Among authors: farcet jp. Ann Rheum Dis. 2004 Apr;63(4):467-8. doi: 10.1136/ard.2003.006965. Ann Rheum Dis. 2004. PMID: 15020352 Free PMC article. No abstract available.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet JP, Sobhani I. Le Gouvello S, et al. Among authors: farcet jp. Gut. 2008 Jun;57(6):772-9. doi: 10.1136/gut.2007.123794. Epub 2007 Oct 26. Gut. 2008. PMID: 17965063
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.
Amiot A, Hulin A, Belhassan M, Andre C, Gagniere C, Le Baleur Y, Farcet JP, Delchier JC, Hüe S. Amiot A, et al. Among authors: farcet jp. Clin Res Hepatol Gastroenterol. 2016 Feb;40(1):90-8. doi: 10.1016/j.clinre.2015.05.019. Epub 2015 Jun 29. Clin Res Hepatol Gastroenterol. 2016. PMID: 26138132
IL4I1: an inhibitor of the CD8⁺ antitumor T-cell response in vivo.
Lasoudris F, Cousin C, Prevost-Blondel A, Martin-Garcia N, Abd-Alsamad I, Ortonne N, Farcet JP, Castellano F, Molinier-Frenkel V. Lasoudris F, et al. Among authors: farcet jp. Eur J Immunol. 2011 Jun;41(6):1629-38. doi: 10.1002/eji.201041119. Epub 2011 May 13. Eur J Immunol. 2011. PMID: 21469114 Free PMC article.
130 results